Skip Navigation LinksHome > July 2012 - Volume 5 - Issue 7 > Clinical Trial Alert
Text sizing:
A
A
A
Nephrology Times:
doi: 10.1097/01.NEP.0000418525.23998.03
Clinical Trial Alert

Clinical Trial Alert

Free Access

The following is a partial list of new clinical trials recently added to the National Institutes of Health's ClinicalTrials.gov online registry. More information on these trials is available at www.clinicaltrials.gov.

Back to Top | Article Outline

• Acute Kidney Injury •

NCT01621152

Prevention of Acute Kidney Injury Initiated with Electronic Surveillance Enhancement (PRAISE)

Ages eligible for study: 18 years and older

Sponsors and collaborators: Mayo Clinic

Contact: Kianoush Kashani, MD

Phone: 507-266-7093

E-mail: kashani.kianoush@mayo.edu

Contact: Abbasali Akhoundi, MD

Phone: 507-266-7093

E-mail: akhoundi.abbasali@mayo.edu

Back to Top | Article Outline
NCT01602328

A Study to Evaluate the Safety and Efficacy of AC607 for the Treatment of Kidney Injury in Cardiac Surgery Subjects (ACT-AKI)

Ages eligible for study: 21 years and older

Sponsors and collaborators: AlloCure

Contact: Elizabeth A. LaPointe, MA

Phone: 978-400-8126

E-mail: elapointe@allocure.com

Contact: Viken Paragamian

Phone: 416-427-1475

E-mail: vikp@allocure.com

Back to Top | Article Outline
NCT01594489

Aminophylline and Contrast-Induced Nephropathy in Acute Myocardial Infarction

Ages eligible for study: 18 years and older

Sponsors and collaborators: Ospedale Misericordia e Dolce (Misericordia and Dolce Hospital)

Contact: Mauro Maioli, MD

Phone: +39 0574 434396

E-mail: mauro.maioli@fastwebnet.it

Back to Top | Article Outline
NCT01625403

Recombinant BNP on Heart and Renal Function in Acute Heart Failure

Ages eligible for study: 18 years to 80 years

Sponsors and collaborators: Shanghai Chest Hospital

Contact: Fang Yuan

E-mail: yuanfangysh@126.com

Back to Top | Article Outline

• Anemia •

NCT01599507

Study of FG-4592 in Subjects with Chronic Kidney Disease in China

Ages eligible for study: 18 years to 75 years

Sponsors and collaborators: FibroGen

Contact: Dalvin Ni, MD, PhD

Phone: 86-13901772047

E-mail: dni@fibrogen.com

Contact: Frank Valone, MD

Phone: 415-978-1520

E-mail: fvalone@fibrogen.com

Back to Top | Article Outline

• Diabetes •

NCT01617824

Rapid Effects of Linagliptin on Monocyte Polarization in Type 2 Diabetes

Ages eligible for study: 35 years to 75 years

Sponsors and collaborators: University of Padova

Contact: Angelo Avogaro, MD, PhD

Phone: +39 049 8212178

E-mail: angelo.avogaro@unipd.it

Contact: Gian Paolo Fadini, MD

Phone: +39 049 8214318

E-mail: gianpaolo.fadini@unipd.it

Back to Top | Article Outline
NCT01601236

Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients

Ages eligible for study: 18 years and older

Sponsors and collaborators: Questcor Pharmaceuticals

Contact: Jay Elliott

Phone: 513-579-9911, ext. 2032

E-mail: j.elliott@medpace.com

Contact: Mary Nyberg

Phone: 443-973-2015

E-mail: mary.nyberg@questcor.com

Back to Top | Article Outline

• Hemodialysis •

NCT01612429

Carbamylation in Renal Disease Modulation with Amino Acid Therapy (CarRAAT)

Ages eligible for study: 18 years and older

Sponsors and collaborators: Massachusetts General Hospital

Contact: Sahir Kalim, MD

Phone: 617-726-5050

E-mail: skalim@partners.org

Contact: Dorothy Sullivan, RN

Phone: 617-726-5382

E-mail: dsullivan18@partners.org

Back to Top | Article Outline

• Hypertension •

NCT01617551

Effect of Renal Denervation on NO-Mediated Sodium Excretion and Plasma Levels of Vasoactive Hormones (RENO)

Ages eligible for study: 30 years to 70 years

Sponsors and collaborators: Regional Hospital Holstebro, Aarhus University Hospital

Contact: Jesper N. Bech, MD, PhD

Phone: +45 41627639

E-mail: jnbech@dadlnet.dk

Back to Top | Article Outline
NCT01609959

New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood-Pressure Lowering (NARA)

Sponsors and collaborators: Nara Medical University

Contact: Yoshihiko Saito, MD, PhD

Phone: +81-744-22-3051, ext. 3411

E-mail: yssaito@naramed-u.ac.jp

Contact: Sadanori Okada, MD, PhD

Phone: +81-744-22-3051, ext. 3411

E-mail: saokada@naramed-u.ac.jp

Back to Top | Article Outline

• Transplantation •

NCT01609673

Study of Everolimus in De Novo Renal Transplant Recipients

Ages eligible for study: 18 years to 85 years

Sponsors and collaborators: Novartis Biociências SA (Novartis Biosciences SA)

Contact: Hélady S. Pinheiro, MD, PhD

Phone: +55 (32) 9982 8439

E-mail: heladysanders@gmail.com

Contact: Maria S. van Keulen, RN

Phone: +55 (32) 8437 6754

E-mail: maria.keulen@hotmail.com

Back to Top | Article Outline
NCT01615341

Study of Subclinical Viral Infection

Ages eligible for study: 1 year to 25 years

Sponsors and collaborators: Seattle Children's Hospital, University of Washington

Contact: Jodi Smith, MD

Phone: 206-987-2524

E-mail: jodi.smith@seattlechildrens.org

Contact: Shannon Granillo

Phone: 206-884-1418

E-mail: shannon.granillo@seattlechildrens.org

Back to Top | Article Outline
NCT01615900

Randomized Open-Label Study Evaluating the Coverage by Teleconsultation Versus Standard Follow-Up of Renal Transplant Patients According to a Risk Score of Early Graft Failure (KTFS) (TELEGRAFT)

Ages eligible for study: 18 years and older

Sponsors and collaborators: Nantes University Hospital

Contact: Aurélie Meurette

Phone: +33 2 40 08 74 35

E-mail: aurelie.meurette@chu-nantes.fr

Back to Top | Article Outline
NCT01622881

Analgesic Efficacy of Nefopam in Patients Undergoing Kidney Transplantation

Ages eligible for study: 20 years to 59 years

Sponsors and collaborators: Severance Hospital

Contact: Yong Seon Choi, MD, PhD

Phone: 82-2-2227-4576

E-mail: yschoi@yuhs.ac

Contact: So Yeon Kim, MD, PhD

Phone: 82-2-2227-4470

E-mail: kimsy326@yuhs.ac

Back to Top | Article Outline
NCT01608412

A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus

Ages eligible for study: 18 years and older Sponsors and collaborators: Hospital de Clinicas de Porto Alegre (Clinical Hospital of Porto Alegre)

Contact: Luiz Felipe S. Gonçalves, MD

E-mail: lfgoncalves@hcpa.ufrgs.br

Contact: Nisséia Jahn, RN

E-mail: nisseia@yahoo.com.br

Back to Top | Article Outline
NCT01612299

Effects of Zortress plus Tacrolimus Versus Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in De Novo Renal Transplant Recipients

Sponsors and collaborators: University of Kentucky

Contact: Hartmut Malluche, MD

Phone: 859-323-5049

E-mail: hhmall@uky.edu

Contact: Roberto Gedaly, MD

Phone: 859-323-4661

E-mail: rgeda2@uky.edu

Back to Top | Article Outline
NCT01602861

The Effects of Spironolactone on Calcineurin Inhibitor-Induced Nephrotoxicity (SPIREN)

Ages eligible for study: 18 years and older

Sponsors and collaborators: Odense University Hospital, Fredericia Hospital

Contact: Line A. Mortensen, MD

Phone: 0045 30299610

E-mail: line_maas@hotmail.com

Back to Top | Article Outline
NCT01614665

A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Antirejection Medication Tacrolimus (Advagraf or Prograf) in Children Receiving an Organ Transplant, and How Safe and Effective They Are over a Longer Period of Time

Ages eligible for study: up to 15 years

Sponsors and collaborators: Astellas Pharma Europe

Contact: Medical Affairs Europe

Phone: +44 1784 419400

E-mail: contact@nl.astellas.com

Back to Top | Article Outline

• Vascular Access •

NCT01604473

Endothelial Function and Arteriovenous Fistula Maturation

Ages eligible for study: 18 years to 90 years

Sponsors and collaborators: University of California, San Francisco

Contact: Hugh F. Alley

Phone: 415-221-4810, ext. 4708

E-mail: hugh.alley@ucsfmedctr.org

Contact: Christine Hall

Phone: 415-221-4810, ext. 2115

E-mail: christine.hall@ucsfmedctr.org

Back to Top | Article Outline
NCT01597115

Enhancing Maturation of Autogenous Arteriovenous Hemodialysis Access by Aggressive Surveillance with Duplex and Endovascular Treatment (ENHANCE)

Ages eligible for study: 20 years to 70 years

Sponsors and collaborators: Seoul National University Hospital

Contact: Sang-Il Min

Phone: 82-2-2072-2330

E-mail: surgeonmsi@gmail.com

Back to Top | Article Outline
NCT01601873

Propaten Randomized Investigation on Cost–Benefit and Efficacy (PRICE)

Ages eligible for study: 18 years and older

Sponsors and collaborators: University of Texas Health Science Center at Houston

Contact: Kristofer M. Charlton-Ouw, MD

Phone: 713-486-5100

E-mail: kristofer.charltonouw@uth.tmc.edu

Contact: Harleen K. Sandhu, MD

Phone: 713-486-5100

E-mail: harleen.k.sandhu@uth.tmc.edu

Back to Top | Article Outline

• Miscellaneous •

NCT01604577

Targeting Social Determinants to Improve Chronic Kidney Disease Care

Ages eligible for study: 18 years to 80 years

Sponsors and collaborators: Vanderbilt University

Contact: Kerri Cavanaugh, MD

Phone: 615-936-7306

E-mail: kerri.cavanaugh@vanderbilt.edu

Back to Top | Article Outline
NCT01624064

Renal Effects of an Angiotensin-Converting Enzyme Inhibitor in Adults with Chronic Kidney Disease of Uncertain Etiology (CKDu)

Ages eligible for study: 18 years to 70 years

Sponsors and collaborators: Ministry of Health, Sri Lanka; World Health Organization

Contact: Selvarajah Mathu, MBBS, MD

Phone: 94-77-7390628

E-mail: mathuselvarajah@yahoo.com

Contact: Navaratnasingam Janakan, MBBS, MSc, MD

Phone: 94-77-7489813

E-mail: navajanakan@yahoo.com

Back to Top | Article Outline
NCT01616927

Study of Lanreotide to Treat Polycystic Kidney Disease (DIPAK1)

Ages eligible for study: 18 years to 60 years

Sponsors and collaborators: University Medical Center Groningen, Leiden University Medical Center, Erasmus Medical Center, Radboud University

Contact: Esther Meijer, MD, PhD

E-mail: esther.meijer@umcg.nl

Contact: Ron Gansevoort, MD, PhD

E-mail: r.t.gansevoort@umcg.nl

Back to Top | Article Outline
NCT01604395

Long-Term Safety and Effectiveness of Growth Hormone with GHD (Growth Hormone Deficiency), TS (Turner Syndrome), CRF (Chronic Renal Failure), SGA (Small for Gestational Age), and ISS (Idiopathic Short Stature) in Children (LGS)

Ages eligible for study: 2 years and older

Sponsors and collaborators: LG Life Sciences

Contact: YoungHwan Jang

Phone: 82-2-6924-3158

E-mail: younghj@lgls.com

© 2012 Lippincott Williams & Wilkins, Inc.

Login